Overall Status

Completed (135)

Not yet recruiting (18)

Unknown status (17)

Terminated (11)

Recruiting (10)

Active, not recruiting (6)

Suspended (3)

Withdrawn (2)

Phase

n/a (53)

phase 3 (50)

phase 4 (43)

phase 1 (15)

phase 2 (12)

phase 2/phase 3 (9)

phase 1/phase 2 (5)

Study Documents

Individual Participant Data Set (2)

Assessment report: Eurartesim - dihydroartemisinin / piperaquine phosphate EMEA/H/C/1199 (1)

Clinical Study Report (1)

Dataset Specification (1)

Informed Consent Form (1)

Statistical Analysis Plan (1)

Study Protocol (1)

Intervention Type

drug (180)

other (17)

dietary supplement (10)

biological (7)

behavioral (5)

device (4)

diagnostic test (3)

combination product (2)

procedure (1)

Funder Type

Other (164)

U.S. Fed (16)

Industry (12)

NIH (10)

Study Type

Interventional (187)

Observational (12)

Observational [Patient Registry] (3)

Sulfadoxine

Showing 201 - 202 of 202

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HIV, Malaria, Diarrhea Trial in Kisumu (Cotrimoxazole (trimethoprim sulfamethoxazole))

Completed

HIV
+4 more

Cotrimoxazole (trimethoprim sulfamethoxazole)

Kisumu, Kenya

CDC KEMRI Research Institute

Dec 12, 2005

Falciparum Malaria, Vivax Malaria Trial in Timika (Chloroquine and sulphadoxine-pyrimethamine)

Completed

Falciparum Malaria
Vivax Malaria

Chloroquine and sulphadoxine-pyrimethamine

Timika, Papua, Indonesia

SP9 & SP12 Public Health- Malaria control clinics

Sep 7, 2005